(Q79443179)

English

A low-dose combination therapy of interleukin-2 and interferon-alpha is effective for lung metastasis of renal cell carcinoma: a multicenter open study

scientific article published on 25 December 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

A low-dose combination therapy of interleukin-2 and interferon-alpha is effective for lung metastasis of renal cell carcinoma: a multicenter open study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

renal cell carcinoma

1 reference

based on heuristic

inferred from title

lung metastasis

1 reference

based on heuristic

inferred from title

Taiji Tsukamoto

2

object named as

Taiji Tsukamoto

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Hideyuki Akaza

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Tetsuro Onishi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Tsuneharu Miki

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Toshiaki Kinouchi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Seiji Naito

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

25 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

International Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

434-440

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Distinct clinical and laboratory activity of two recombinant interleukin-2 preparations

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy for metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An assessment of the current use of human interferons in therapy of urological cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Response criteria for urological cancer treatment]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of human interleukin 2 derived from Escherichia coli

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Adminis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17180511

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10147-006-0596-Z

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17180511%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79443179&oldid=2222820666"